DIABETIC KETOACIDOSIS
|
|
- Ashlyn Simon
- 5 years ago
- Views:
Transcription
1 DIABETIC KETOACIDOSIS DANA BARTLETT, BSN, MSN, MA, CSPI Dana Bartlett is a professional nurse and author. His clinical experience includes 16 years of ICU and ER experience and over 20 years of as a poison control center information specialist. Dana has published numerous CE and journal articles, written NCLEX material, written textbook chapters, and done editing and reviewing for publishers such as Elsevire, Lippincott, and Thieme. He has written widely about toxicology and was recently named a contributing editor, toxicology section, for Critical Care Nurse journal. He is currently employed at the Connecticut Poison Control Center and is actively involved in lecturing and mentoring nurses, emergency medical residents and pharmacy students. ABSTRACT Diabetic ketoacidosis is an acute complication of diabetes mellitus, which requires prompt, aggressive, treatment. Complications of diabetic ketoacidosis throughout the age spectrum and during pregnancy require a close evaluation of symptoms, testing, treatment and outcomes to treatment. Anyone with diabetes, regardless of age or gender, can develop ketoacidosis. Guidelines exist that guide diabetes health teams and clinical care of the diabetic patient. Appropriate and timely treatment can reduce diabetic ketoacidosis complications and patients can recover to full health. 1
2 Policy Statement This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses. It is the policy of NurseCe4Less.com to ensure objectivity, transparency, and best practice in clinical education for all continuing nursing education (CNE) activities. Continuing Education Credit Designation This educational activity is credited for 2 hours. Nurses may only claim credit commensurate with the credit awarded for completion of this course activity. Statement of Learning Need Diabetes mellitus is one of the leading chronic diseases in the country and diabetic ketoacidosis is one of the most serious complications. When patients in diabetic ketoacidosis crisis receive the right treatment they are able to recover and to improved health. Health clinicians need to be able to identify prevalence and treatment of diabetes ketoacidosis in all age groups and for special conditions, such as pregnancy. 2
3 Course Purpose To help clinicians early identify signs and symptoms of diabetic ketoacidosis and its recommended treatment. Target Audience Advanced Practice Registered Nurses and Registered Nurses (Interdisciplinary Health Team Members, including Vocational Nurses and Medical Assistants may obtain a Certificate of Completion) Course Author & Planning Team Conflict of Interest Disclosures Dana Bartlett, BSN, MSN, MA, CSPI, William S. Cook, PhD, Douglas Lawrence, MA, Susan DePasquale, MSN, FPMHNP-BC all have no disclosures. Acknowledgement of Commercial Support There is no commercial support for this course. Please take time to complete a self-assessment of knowledge, on page 4, sample questions before reading the article. Opportunity to complete a self-assessment of knowledge learned will be provided at the end of the course. 3
4 1. Which of the following is the correct definition of diabetic ketoacidosis (DKA)? a. Metabolic disorder with hyperglycemia, metabolic acidosis, elevated ketones. b. Metabolic disorder with normal glucose, metabolic alkalosis, elevated ketones. c. Endocrine disorder caused by inappropriate insulin secretion. d. Endocrine disorder caused by abnormal carbohydrate metabolism. 2. The two most common causes of diabetic ketoacidosis (DKA) are: a. Atypical antipsychotics and gestational diabetes. b. Infection and poor compliance with medication regimens. c. CVA and pregnancy. d. Glucagon-producing tumors, sepsis. 3. The diagnostic criteria of diabetic ketoacidosis (DKA) include: a. A serum ph > 7.5, a serum glucose > 250 mg/dl. b. A serum ph < 7.30, a serum glucose < 250 mg/dl. c. A serum ph > 7.2, a serum glucose < 125 mg/dl. d. A serum ph < 7.3, a serum glucose > 250 mg/dl. 4. The serum potassium in diabetic ketoacidosis (DKA) is: a. Typically very low. b. Deceptively high: there is actually profound hypokalemia. c. Typically normal. d. Deceptively low: the total body content is normal. 5. Pregnant women who have diabetic ketoacidosis (DKA): a. Always have elevated serum glucose. b. Are rarely acidotic. c. May be euglycemic. d. Have a high mortality rate. 4
5 Introduction Diabetic ketoacidosis is a very serious complication of diabetes mellitus, a metabolic disorder that is characterized by hyperglycemia, metabolic acidosis, and increased ketone body concentrations. The most common causes of diabetic ketoacidosis (DKA) are infection and poor compliance with medication regimens. Other causes include undiagnosed diabetes, alcohol use, stress and a multitude of medical conditions such as cerebrovascular accident (CVA), complicated pregnancy, myocardial infarction (MI) and pancreatitis. DKA is a complicated pathology. Early recognition and a good understanding of the pathological processes of DKA, and aggressive treatment are the keys to successful treatment. With appropriate care, DKA can be managed and the patient is able to survive. Epidemiology Most cases of DKA are seen in patients with type 1 diabetes, 1 but approximately 20%-30% of all cases of DKA occur in patients with type 2 diabetes. 1,2 The incidence of DKA in the United States is increasing, 1 and the incidence of DKA in people who have type 2 diabetes appears to be increasing, as well. 2.3 There is also a variation of type 2 diabetes, ketosis-prone diabetes, that is common in African Americans and Hispanic Americans and this subgroup of diabetic patients is particularly likely to develop DKA. 4 Between 20% and 67% of children diagnosed with type 1 diabetes present with diabetic ketoacidosis, 5-7 and the yearly risk for DKA in this patient population is 1%-10%. 8 5
6 The mortality rate of DKA in adults is approximately <1% to <2%, 1,9 it is higher in the elderly and in patients with serious comorbidities, 10 and DKA is a leading cause of mortality in children and adolescents who have type 1 diabetes. 8,9,11 Glucose, Insulin, And Diabetes: A Brief Review Glucose is an essential source of energy. For glucose to be used for energy it must be transported into the cells, but the glucose molecule is too large to passively move through the cell membrane. Glucose must be actively carried into the cell and that is the function of insulin; it is a transport molecule. This section briefly reviews how the body utilizes glucose to function. Glucose and Energy The body needs energy to function, and a great deal of this energy is provided by glucose. Glucose is derived from the breakdown of foods consumed (particularly carbohydrates) and glucose is converted into adenosine triphosphate (ATP) by the glycolytic pathway. Adenosine triphosphate provides energy for basic body functions when the high energy bonds of the ATP molecule are broken down. The process by which insulin promotes glucose entry into the cells is called facilitated diffusion. This process is not completely understood, but it may be that when insulin binds to an insulin receptor on a cell membrane, it increases the membrane concentration of Glut4, which is a glucose transporter. 6
7 In the normal person, blood glucose is maintained within a narrow range of mg/dl, and fasting glucose for adults should be mg/dl. Close control of blood glucose is important, as glucose is the only nutrient that can be used by important organs such as the brain, retina, etc. When blood glucose rises, such as after a meal, the secretion of insulin rises dramatically, both in the amount and the speed in which this rise occurs, as glucose enters the pancreatic β cells and stimulates insulin release. Diabetes is a disease that affects glucose metabolism. There are essentially two types of diabetes - Type 1 (also called juvenile onset diabetes) and Type 2 (also called adult onset or non-insulin-dependent diabetes). Type 1 diabetes is caused by destruction of the pancreatic β cells that produce insulin. The destruction of the β cells is thought to be an autoimmune process that occurs in genetically susceptible people and is triggered by an infection or an environmental factor. People with type I diabetes essentially do not produce insulin. Whereas, type 2 diabetes is characterized for the most part by insulin resistance and inadequate insulin secretion. Due to age, genetics, lifestyle factors, and possibly environmental triggers, the body is unable to use insulin to transport glucose into the cells. In both type 1 and type 2 diabetes, medications and lifestyle modifications are needed so that blood glucose remains within a specified range. Type 1 and Type 2 Diabetes Classification System: Out of Date? Diabetes mellitus has traditionally been classified as type 1 or type 2, but there is growing recognition that not everyone with diabetes mellitus can be described by one of those two categories. 13 Many 7
8 researchers now feel that the age of onset, the presence or absence of auto-antibodies, and the functioning of the β cells should be considered when classifying diabetes as these factors may have important clinical considerations. Thomas, et al., (2015) noted that the existing classification systems are to some degree inconsistent and have some overlaps; the classification of diabetes is still evolving, and it is difficult to classify diabetes... in the absence of a complete understanding of the pathogenesis of the major forms. 13 The classification system used by the American Diabetic Association (ADA) will be used here. 14 This system recognizes the complexity of the disease and notes that... for clinician and patient, it is less important to label the particular type of diabetes than it is to understand the pathogenesis of the hyperglycemia and to treat it effectively. 14 8
9 There are many causes of diabetes that will be discussed in a later section. ADA CLASSIFICATION OF DIABETES Type 1 Type 2 Other Specific Types Gestational Diabetes To further illustrate the complexity of the disease, the following subclassifications are included. 13 Type 1 diabetes can be classified as type 1a, type 1b, latent autoimmune diabetes of adults, or as type 1 diabetes associated with the IPEX syndrome. Other specific types of type 1 diabetes include the monogenic forms of the disease, neonatal monogenic diabetes (permanent or transient and mature onset diabetes of the young (MODY). Monogenic diabetes is caused by a mutation of a single disease and it accounts for approximately 1%-5% of all cases of diabetes in children. Gestational Diabetes: Pregnancy can cause diabetes, and gestational diabetes may be a self-limiting condition or predispose the patient to developing type 2 diabetes. Type 2 diabetes occur in people who have a low body mass index (BMI). 9
10 Diseases and diabetes: Diabetes can be caused by many diseases, including (but not limited to) acromegaly, cystic fibrosis, hepatitis C, HIV infection, and pancreatitis. Drugs and diabetes: Diabetes can be caused by drugs, including (but not limited to) antipsychotics and glucocorticoids. Pathophysiology Of DKA The two primary pathogenic mechanisms of DKA are insulin deficiency and elevated levels of counter-regulatory hormones such as catecholamines, cortisol, and glucagon. 1,9 Insulin deficiency can be absolute (when no insulin is produced or no insulin is administered) or it can be relative (when the amount of insulin available is not sufficient to the needs). In either case, insulin deficiency causes hyperglycemia and this hyperglycemia and the elevated levels of counter regulatory hormones are the cause of signs, symptoms, and metabolic derangements of DKA. This process is outlined below. 1,9 The hyperglycemia of DKA stimulates the body to increase production of the hormones cortisol, epinephrine, glucagon, and growth hormone to produce energy; the patient s blood glucose is very high but insulin deficiency prevents glucose movement into the cells. These hormones break down fats to provide the body with energy and stimulate the liver to increase fatty acid oxidation. They also increase blood glucose by initiating gluconeogenesis and glycogenolysis, and by decreasing the ability of peripheral tissues to use glucose. The body now depends on fats for energy instead of carbohydrates and one of the byproducts of fat metabolism is ketones. The ketones produced during DKA, 10
11 acetoacetate and beta-hydroxybutyrate, dissociate to produce hydrogen ions, thus causing metabolic acidosis. Pathophysiology, Signs and Symptoms of DKA The following are conditions associated with DKA. Diuresis High serum glucose causes an osmotic diuresis. Electrolyte disturbances Osmotic diuresis, nausea, and vomiting cause loss of calcium, magnesium, phosphate, and potassium. Metabolic acidosis causes potassium to move from the intracellular space to the extracellular space. Increased metabolic rate The increased metabolic rate of DKA is caused by increased/excessive glycogenolysis and gluconeogenesis, increased respiratory rate, dehydration, elevated levels of circulating catecholamines, and other physiologic demands of DKA. Increased respiratory rate Compensation for the metabolic acidosis. Metabolic acidosis Breakdown of ketone bodies. Nausea and vomiting Caused by metabolic acidosis, worsens dehydration. Precipitating Causes Of DKA Diabetic ketoacidosis is driven by insulin deficiency and elevated levels of counter-regulatory hormones, but there must also be a precipitating cause, a triggering event. The most common precipitating causes of DKA are 1) infection, 2) new diagnosis of diabetes mellitus, 3) poor adherence to treatments, and 4) other causes. 1 11
12 Other precipitating causes of DKA are conditions/illnesses including (but not limited to) acromegaly, alcohol use, cerebrovascular accident, myocardial infarction, pancreatitis, pregnancy, trauma, and drugs, including (but not limited to) antipsychotics, cocaine, glucocorticoids, interferon, sympathomimetics, thiazide diuretics, and sodium-glucose co-transporter-2 inhibitors. 1,9,10,15-18 These pathologies, conditions, and drugs can initiate DKA by increasing the production of stress hormones, elevating the serum glucose, or blunting the normal physiological warning signs of hyperglycemia and acidosis. Acute gastroenteritis, cellulitis, respiratory tract infections, urinary tract infections, and mixed infections are common precipitating factors of DKA. 19,20 DKA initiated by gestational diabetes and DKA initiated by antipsychotics are discussed later on. Clinical Signs And Symptoms Of DKA Diabetic ketoacidosis develops quickly, typically over a period of hours to one day. 1,10 The presentation of DKA will depend on may factors and it can be mild to severe. The patient may be awake and alert but complain of abdominal pain, fatigue, malaise, and nausea or he/she may be comatose, hypotensive, profoundly acidotic, and have significant metabolic derangements. Symptoms of DKA include abdominal pain, drowsiness, fatigue, nausea, polydipsia, and polyuria. 1,10 Signs of DKA often include an acetone odor of the breath (often described a fruity smell), a notably altered sensorium (coma in severe cases), diaphoresis, pallor, hypotension, hypothermia, tachycardia, and tachypnea. These signs and symptoms are non-specific and certainly not exclusive to DKA, but if the pathological processes of DKA are examined the genesis of these 12
13 signs and symptoms and of the common presentation of DKA becomes clear. Several clinical examples are provided below. Example #1 Hypotension in the patient who has DKA is caused by dehydration, and dehydration in DKA is caused by poor oral intake, Kussmaul s respirations, nausea and vomiting, polyuria, and the osmotic diuresis caused by hyperglycemia. Example #2 Abdominal pain, nausea and vomiting are very common in patients who have DKA. Acidosis, elevated serum potassium, and high serum ketone levels cause these gastrointestinal complaints. Example #3 Kussmaul s respirations is defined as deep, labored, and rapid breathing, it is caused by metabolic acidosis, and it is an adaptive response to the high blood levels of carbon dioxide (CO 2 ). This breathing pattern can also contribute to dehydration. Occasionally the patient s breath will have what can be described as a fruity odor; this is caused by excess production of ketones. Diagnosis Of DKA The signs and symptoms of DKA can in hindsight be easily attributed to DKA if the clinician is aware that the patient has diabetes or has a risk factor for DKA. However, the clinical presentation of DKA is non- 13
14 specific and laboratory testing is needed for definitive proof that a patient has DKA. Laboratory Tests The laboratory abnormalities that are the diagnostic criteria for DKA are 1) hyperglycemia, 2) ketonemia, and 3) metabolic acidosis. 1,9 Diabetic ketoacidosis is often classified using those three laboratory tests, and several others, as being mild, moderate, or severe. 1,9 MILD DKA Glucose: > 250 mg/dl Ketones: Positive Arterial ph: Bicarbonate: meq/l Anion gap: >10 Elevated serum osmolality MODERATE DKA Glucose: > 250 mg/dl Ketones: Positive Arterial ph: Bicarbonate: 10 - < 15 meq/l Anion gap: >12 Elevated serum osmolality SEVERE DKA Glucose: > 250 mg/dl Ketones: Positive Arterial ph: < 7.00 Bicarbonate: < 10 Anion gap: >12 Elevated serum osmolality These categories are to some degree imprecise, but they provide a useful framework for characterizing the severity of DKA. It is not 14
15 unusual for the serum glucose of a patient who has DKA to be much higher than 250 mg/dl, and levels of 500 mg/dl are not uncommon. Serum and urine ketones are positive in DKA, and in DKA there are three ketone bodies that are produced, acetone, acetoacetate, and β- hydroxybutyrate. The primary ketone produced in DKA is β- hydroxybutyrate, but commonly used urine dipsticks that are used to check urine for ketones have a poor specificity for β-hydroxybutyrate so there is the possibility of false negatives. Direct measurement of β- hydroxybutyrate is preferred 1,10 and a level > 3 mg/dl is considered abnormal. Other laboratory test abnormalities that occur in DKA are discussed below. Hyperkalemia Acidosis, release of potassium from the cells caused by glycogenolysis, insulin deficiency, and several other mechanisms all cause potassium to shift from the intracellular space to the extracellular space and serum hyperkalemia is common. However, the osmotic diuresis and vomiting that are commonly part of DKA cause potassium to be excreted in the urine and lost in the vomit. The serum potassium level may be high, but the patients are often very depleted of potassium. 9,10 Hyponatremia Hyperglycemia causes an osmotic shift of fluid into the vascular space and a subsequent hyponatremia. Sodium is also lost renally because of the osmotic diuresis. Some sources report that each 100 mg/dl of glucose above the top normal will lower the serum sodium by meq/l. 10 So if the patient s serum glucose is 420 mg/dl and the serum 15
16 sodium is 118 meq/l, the corrected serum sodium would be meq/l. Other Electrolytes Serum calcium, magnesium, and phosphate are lost through diuresis. 9 Initially the serum phosphate may be normal or even high because insulin deficiency and acidosis will move phosphate out of the cells, but the developing acidosis along with poor intake and diuresis will eventually result is significant phosphate losses. 10 Amylase and Lipase Elevated serum amylase and lipase are commonly seen in patients who have DKA. 9,10 Pancreatitis is a well-known cause of DKA and can explain these laboratory abnormalities, but elevated serum amylase and lipase often accompany DKA when pancreatitis is absent. Hepatic Transaminases The hepatic transaminases can be elevated in DKA. This can be from DKA alone or a combination of DKA and fatty liver disease. Leukocytosis An elevated white blood cell count is common and is caused by hemoconcentration and by stress. 9 Diabetic ketoacidosis is often precipitated by an infection however, and a very high white blood cell count should prompt the clinician to look for an infection. 16
17 Serum Osmolality Serum osmolality is often elevated. Renal Function Studies The blood urea nitrogen (BUN) and serum creatinine are often elevated in patients who have DKA. These results can be explained by volume depletion, pre-renal azotemia, or by a laboratory error caused by interference by ketones. 10 The last of these is unlikely with testing methods that are currently used. Troponin Levels An elevated cardiac troponin level in the absence of myocardial damage may be seen in patients who have DKA. 21,22 This may be caused by acidosis or reflect what is called silent ischemia. 22 LABORATORY ABNORMALITIES OF DKA Hypocalcemia Hypomagnesemia Hyperkalemia Hyponatremia Hypophosphatemia Elevated amylase and lipase Elevated hepatic enzymes Elevated BUN and creatinine Elevated cardiac troponin Leukocytosis Hyperosmolality 17
18 It is important to remember that laboratory values in a patient who has DKA can be misleading as the length and severity of the DKA, the clinical signs and symptoms, and the stage of treatment affect these values. For example, serum sodium, phosphate, and potassium may be low, normal, or high, but the measurements must always be interpreted with caution and with the knowledge that they often may not reflect the true levels. Additionally, several of the diagnostic criteria of DKA must be interpreted carefully; for example, normal serum glucose has been reported in pregnant women who have DKA. Serum and urine ketones are positive in DKA, but in DKA there are three ketone bodies, acetone, acetoacetate, and β-hydroxybutyrate. The primary ketone produced in DKA is β-hydroxybutyrate, but commonly used urine dipsticks that are used to check urine for ketones have a poor specificity for β-hydroxybutyrate so there is the possibility of false negatives. Euglycemic DKA Euglycemic DKA in pregnancy is well described and discussed in more detail later on. It is described as a rare phenomenon in patients who are not pregnant. 23 Causes of euglycemic DKA include a pre-existing fasting state, decreased hepatic stores of glucose, decreased hepatic glucose production, and greater than normal urinary losses of glucose. Some drugs, notably the sodium-glucose co-transporter 2 inhibitors, can cause euglycemic DKA, 18 and it can happen if an insulin-dependent diabetic is not eating sufficient carbohydrates but is still taking insulin
19 It is important to remember that euglycemia means normal serum glucose. In the typical case of euglycemic diabetic ketoacidosis a patient s serum glucose is low when compared to the level of hyperglycemia that is typically seen in DKA, but the level is usually (but not always) abnormally elevated. Gestational Diabetes And DKA Diabetic ketoacidosis caused by gestational diabetes is a serious complication of pregnancy. 25 The incidence of gestational diabetes is approximately 9%, 26 and fortunately DKA is uncommon, occurring in about 0.5%-10% of this patient population. 25 Gestational diabetes occurs to women who do not have a prior history of diabetes and the basic cause is increased insulin resistance caused by pregnancy. 26 The precipitating factors of DKA in gestational diabetes are essentially the same as for DKA in men and in women who are not pregnant, and some of the more common ones are listed below. 25,27,28 PRECIPITATING FACTORS OF DKA IN GESTATIONAL DIABETES ß 2 agonists Dehydration Undiagnosed diabetes mellitus Poor compliance with therapy Inadequate calorie intake Infections Protracted vomiting Insulin pump failure Steroid therapy 19
20 Diabetic ketoacidosis occurring during pregnancy tends to happen more quickly than DKA does in women who are not pregnant; it affects women with type 1 diabetes and women with type 2 diabetes, and; it usually develops in the second or third trimester. 25 The clinical presentation of DKA in gestational diabetes is no different than that of DKA in men and non-pregnant women, but it should be remembered that euglycemic DKA with a serum glucose level as low as 96 mg/dl have been reported. 29 Increased glucose uptake by the fetus and the placenta could in part explain euglycemic DKA. In addition, glomerular filtration rate and renal blood flow are increased during pregnancy, but tubular reabsorption of glucose is not increased so excess glucose of DKA may be lost in the urine. If DKA in the pregnant woman is recognized early and treated properly, the outcome for the mother should be good; the maternal mortality rates of DKA have been reported to be < 1.0%, 28 and the rate of fetal death is not high. 25 However, if the condition is not recognized early in its development and/or the appropriate treatments are not given soon enough, serious maternal complications such as acute renal failure, adult respiratory distress syndrome, cerebral edema, euglycemic DKA, pre-term delivery, and myocardial ischemia are possible. 28 In addition, an elevated level of ketoacids during pregnancy has been associated with deficits in psychomotor and neurological development of the child. 25,28 Atypical Antipsychotics And DKA The atypical antipsychotics can cause metabolic disorders such as hyperglycemia, insulin resistance, metabolic syndrome, and type 2 diabetes and these drugs can cause DKA, as well. 34,35 The 20
21 mechanisms by which this occurs are not known and/or incompletely understood; it may be related to weight gain (a very common side effect of these drugs) and insulin resistance, or it may be from previously undiagnosed type 2 diabetes or latent autoimmune diabetes. 34,35 Fortunately, DKA caused by the atypical antipsychotics is rare, as the mortality rate associated with this phenomenon has been reported to be 26.5%. 35 Routine monitoring of patient s weight and BMI (body mass index) is recommended as part of the treatment plan when typical antipsychotics (first generation) and atypical antipsychotics (second generation) are prescribed, and blood glucose and other metabolic markers of diabetes and DKA should be monitored, as well. 34,35 Complications Of DKA Patients who have DKA that is promptly recognized and correctly treated should survive, but both the treatment and DKA can cause serious complications. 1,9 The primary complications of DKA treatment are hypoglycemia, hyperkalemia, and fluid overload. 1,9 These can be prevented with conscientious monitoring of serum glucose, serum potassium, and the patient s fluid status. Complications of DKA (aside from those previously discussed) include, but are not limited to cerebral edema, renal failure, rhabdomyolysis, QTc prolongation, and stroke. 1,9,10,36-43 Many of these are more common in children than adults, i.e., cerebral edema. 1 Cerebral edema is a particularly serious complication of DKA. 21
22 Children, DKA and Cerebral Edema Cerebral edema is a very dangerous consequence of DKA in children. Fortunately, cerebral edema is rare, occurring in 0.5%-1% of all pediatric cases of DKA, 1,9,44 but the mortality rate associated with this complication has been reported to be as high as 90% 44 and many children who have DKA-associated cerebral edema suffer permanent neurological sequelae. 9,44 Cerebral edema in children who have DKA will usually develop within the first seven hours of treatment, but a delay in presentation up to 24 hours is possible. 9,44 Obvious and alarming signs and symptoms may be present or the child may be asymptomatic or have a relatively mild clinical presentation. 44 It is important to remember that DKA-associated cerebral edema is a clinical diagnosis, and neuroimaging studies are likely to be normal in 40% of all children who have this complication. 44 Diagnostic criteria are listed below. DIAGNOSTIC CRITERIA FOR DKA-ASSOCIATED PEDIATRIC CEREBRAL EDEMA Abnormal motor or verbal response to pain Abnormal neurologic respiratory pattern Age-inappropriate incontinence Altered mentation Cranial nerve palsy Decerebrate or decorticate posture Diastolic blood pressure > 90 mm Hg, age < 5 years Difficulty waking from sleep Fluctuating level of consciousness Headache Heart rate deceleration not improve with hydration or sleep Lethargy Vomiting 22
23 There are many reasons why young children are more likely to develop DKA-related cerebral edema. The early signs and symptoms can be non-specific and attributed to a viral illness. Young children cannot communicate how they feel, which can make diagnosing DKA difficult. Also, young children have a higher basal metabolic rate and surface area relative to body weight, therefore, during treatment for DKA they are more likely to suffer from fluid and electrolytes disorders. Finally, for several physiological reasons young children are more vulnerable to cerebral edema. Adolescents are more likely than adults to be noncompliant with their insulin regimen. Treatment For Diabetic Ketoacidosis When assessing a patient for DKA, the clinician should perform a health history, check for the presence or absence of the typical signs and symptoms of DKA, and look for the characteristic laboratory abnormalities that are caused by DKA. In performing the health history, the clinician should be sure to ask the following questions. Does the patient have diabetes and if so, what type? Has the patient been eating properly and drinking sufficient amounts? If the patient uses oral hypoglycemic agents or insulin, has the patient been taking the medications? Has the patient recently had a new medication added to his/her medication regimen? Has the patient recently lost weight or had a fever or infection? 23
24 Treatment of a patient who has or is suspected of having DKA begins with an assessment and a physical exam. The diagnostic and laboratory tests that should be done are listed below: A1c level Serum glucose Serum ketones Urine ketones Arterial or venous blood gas Serum electrolytes Bun and creatinine Serum lactate level Serum osmolality Serum calcium, magnesium, and phosphate 12-lead ECG CT scan of the head Depending on the patient s clinical presentation, serum amylase and lipase, hepatic transaminases, and troponin should be measured. If an infection is suspected, the appropriate diagnostic tests should be done. Treatment of DKA should be focused on 1) fluid replacement, 2) insulin therapy, 3) monitoring for and correcting acid-base disturbances, electrolyte imbalances, and complications, and 4) the assessment for, and treatment of comorbid conditions and precipitating factors. 1,9,46 Fluid Replacement Treatment of DKA should begin with fluid replacement. Fluid replacement will restore intravascular volume, help perfuse the kidneys, stabilize cardiovascular status, and it increases 24
25 responsiveness to insulin. 1,9,45 Patients who have DKA often have a profound fluid deficit of 6 liters or more. 9 Recommendations for the initial infusion rate differ but not to a significant degree. For example, the clinician can infuse fluids at ml/kg/hour of isotonic 0.9% saline for several hours 45 or infuse ml/hour of isotonic 0.9% saline solution for the first 2-4 hours. 1 Regardless of the specific infusion rate that is used, fluid resuscitation is a primary goal in the first few hours of treatment for DKA. The infusion rate recommendations assume the patient is an average sized adult, not in shock, does not have a high risk for cardiac decompensation, and 0.9% isotonic saline solution is the correct fluid to use. 1,9,45,46 After initial fluid resuscitation, the clinician should continue infusing 0.9% isotonic saline if the corrected serum sodium is < 135 meq/l or the patient is still dehydrated. 1,46 If the corrected serum sodium is normal and fluid losses have been replaced, 0.45% saline should be started. Again, there are different recommendations for the infusion rate, i.e., 4-14 ml/kg/hour or ml/hour. 1,46 If the serum glucose level is 200 mg/dl or below, the IV fluids should contain 5%- 10% dextrose; 1,46 this will ensure that insulin therapy can be safely continued. Electrolyte Imbalances There is little mention in the literature about specific therapies for low serum calcium, magnesium, and phosphate. Phosphate replacement may be needed if the serum level is < 1.0 mg/dl or the patient has anemia, cardiac dysfunction, or respiratory dysfunction. 1,9 25
26 Hyponatremia is treated with infusion of IV saline solutions. A patient who has DKA often has a significant total body deficit of potassium, and the aggressive insulin therapy that is used to treat DKA can further lower serum potassium. Profound hypokalemia can have dire consequences and it should be treated aggressively. CORRECTING HYPOKALEMIA IN DKA Serum Potassium < 3.3 meq/l: Do not give insulin. Administer meq/hour of potassium chloride until the serum potassium is > 3.3 meq/l. 46 Serum Potassium meq/l: Add meq of potassium chloride to each liter of IV solution. 46 Serum potassium > 5.3 meq/l: Supplemental potassium is not needed. Check the serum potassium every one to two hours. 46 Insulin Therapy Patients who have moderate to severe DKA should be treated with IV insulin; patients who have mild DKA can be treated with subcutaneous insulin injections. 46 The standard recommendation for IV insulin is to give a bolus dose of regular insulin, 0.1 units/kg, followed by a continuous IV infusion of regular insulin at 0.1 units/kg/hour. 1,46 The clinician should bear in mind that if the patient s serum potassium is < 3.3 meq/l then insulin therapy should be delayed until the serum potassium is > 3.3 meq/l. 46 When the serum glucose is at or close to 200 mg/dl, the rate of the insulin infusion should be decreased, but the IV insulin should be 26
27 continued until the ketoacidosis has resolved, the serum glucose is < 200 mg/dl, and administration of subcutaneous insulin has been started. 46 Ketoacidosis is considered to have been resolved when the anion gap and the beta-hydroxybutyrate levels are normal and the patient can eat. Subcutaneous insulin can be started using the patient s previous insulin protocol. If the patient is insulin naïve, the clinician should administer units/kg a day along with bolus doses and basal insulin until the blood glucose is controlled. 46 The IV insulin infusion should be continued for several hours after the first subcutaneous dose of insulin has been given. 46 The serum glucose level will usually decrease by mg/dl an hour and if it does not, the clinician should double the infusion rate and closely monitor the serum glucose. 46 INSULIN THERAPY FOR DKA Serum Potassium: Do not treat with insulin until the serum potassium is > 3.3 meq. Mild DKA: Treat with subcutaneous insulin. Moderate-Severe DKA: Bolus of 0.1 units/kg regular insulin then a continuous infusion of regular insulin at 0.1 units/kg/hour. Serum glucose ~ 200 mg/dl: Decrease rate of insulin infusion until serum glucose is < 200 mg/dl, ketoacidosis has resolved, and subcutaneous insulin has been started. Subcutaneous insulin: Use the patient s previous insulin protocol. Insulin naïve patients, give units/kg a day with bolus doses and basal insulin until blood glucose is controlled. Continue IV insulin infusion for several hours after the first dose of subcutaneous insulin. 27
28 Acid-Base Disturbances and Bicarbonate Therapy The acidosis caused by DKA can be severe, and acidosis interferes with the effectiveness of therapy and it has many deleterious effects like arrhythmias, cardiac dysfunction, coma, peripheral vasodilation, and shifting the oxyhemoglobin dissociation curve to the left. Given this, correcting the acidosis with IV bicarbonate makes intuitive sense. However, bicarbonate therapy is not recommended as treatment for DKA; there is no proof that it is effective if the patient s ph is 6.9, 1,9,46 and there is evidence that bicarbonate therapy can be harmful by slowing the rate of recovery, increasing the risk for cerebral edema and hypokalemia and depressing ventilatory drive. 1,9,46 The potential for deleterious effects may be especially true for children who have DKA. Bicarbonate therapy should only be used if the serum ph is < 6.9, the patient has severe hyperkalemia, or if the acidosis is causing severe systemic effects. 1,46 If bicarbonate therapy is needed, the clinician should administer 100 meq of sodium bicarbonate with 20 meq of potassium chloride, diluted in 400 ml of sterile water, and infused over two hours. 46 Continuing Care and Monitoring for Complications Arterial or venous ph, serum glucose, potassium, and sodium, serum osmolality, and beta-hydroxybutyrate should be periodically measured; the timing between measurements will depend on previous values, the patient s clinical condition, and the specific therapies being used. 28
29 Common complications of DKA and the treatment of DKA include hypoglycemia, hypokalemia, hyperkalemia, pulmonary edema, and renal failure. These can be prevented by close monitoring of the BUN and creatinine, serum electrolytes, serum glucose, and the patient s intake and output measurements. Treatment Of Cerebral Edema Specific recommendations for treating cerebral edema primarily address the issue of cerebral edema in children and adolescents. General guidelines for treating elevated intracranial pressure include the following interventions. 47 Antiepileptic therapy (done prophylactically if needed). Blood pressure control. Fever: If the patient is febrile, aggressive temperature control is a priority. Position: The patient s head should be elevated. Sedation. Specific therapies that are/may be recommended for children, adolescents, and adults include: 1,46-48 Mannitol: grams/kg, give IV over 20 minutes. The dose may be repeated in 1-2 hours if there is no response. Hypertonic saline: A 3% saline solution, 5-10 ml/kg, give IV over 30 minutes. This is considered a secondary measure, used only if mannitol is not effective. 29
30 Clinical Care, Prevention and Education When providing care for a patient in the acute phase of DKA, the health clinician should focus on hydration status and fluid replacement, monitoring of acid-base status, serum glucose, and serum electrolytes, close observation of the patient s neurological status, and vital signs. Once a case of DKA has resolved it is important to know why it happened. Infections, medical conditions, and drugs are common causes of DKA. However, one of the most important causes of DKA is patient non-compliance with diabetic treatment regimens. Patients do not take their medication or do not take them properly, they fail to follow their prescribed diet and lifestyle plans, and they do not or cannot understand the basics of self-care and prevention as related to diabetes. If noncompliance was the cause of a case of DKA, it is very important to determine why the non-compliance occurred, and there are many possible reasons. Some of the more common reasons are listed below. Poor Access to Medical Care The patient may not have access to health care information, may not have easy access to a physician, clinic, etc., and, may not have or not know how to use community or public access health care resources. The patient also may not have money for medications. Lack of Information The patient may have a poor understanding of diabetes, and the patient may not understand the treatment regimens that have been 30
31 prescribed. Lack of information can be damaging in many ways. If the patient doesn t understand the disease of diabetes, he/she might be less willing to comply with lifestyle and diet restrictions and less willing to take medications. The patient would not recognize possible warning signals of DKA. Emotional Acceptance and Non-compliance For many people, diabetes requires lifestyle changes that they may not be willing to emotionally accept. Although it may be said that noncompliance happens when the patient fails to provide good self-care, the word fail typically has a negative connotation. Also, when many people hear the term non-compliance, they think of a person willfully failing to do what he/she knows is best. However, there are many cases of non-compliance that happen because the patient has not been properly educated, or doesn t have or doesn t know how to get the resources needed. When it has been determined that non-compliance was the cause of DKA, the patient should be interviewed to find 1) the emotional impact of diabetes on the patient s life, 2) how much is known about the disease and treatments, and 3) what financial, medical, personal, and social resources the patient has available for self-treatment. Social workers, psychologists, or the patient s medical clinician must address some of these issues. However, nursing clinicians have a primary role to support and educate patients who have had an incident of DKA related to non-compliance. Nurses will often be the first person to find out that the patient did not seek medical attention for an infection because of financial concerns, 31
32 or due to inability to reach a physician, or because of a lack of understanding of the implications of infection in diabetes. All clinicians in primary care settings must discuss the appropriate patient referrals and establish a teaching plan. Some of the clinical diagnoses that might apply in these situations would be imbalanced nutrition, noncompliance, knowledge deficit, and risk for injury. Summary Diabetic ketoacidosis is a metabolic disorder characterized by hyperglycemia, metabolic acidosis, and elevated body ketone concentrations. The basic cause of DKA is insulin deficiency, absolute or relative. The insulin deficiency most often occurs because of infection or non-compliance with diabetic treatment regimens. However, there are multiple medical conditions that can cause DKA and many medications that can do so as well. Excess hormone concentration and a metabolic shift are the pathogenic mechanisms that cause the signs and symptoms of DKA. The common signs and symptoms of DKA, such as abdominal pain, decreased skin turgor, dehydration, dry mucous membranes, and electrolyte abnormalities, among others have been discussed. Also, the complications in adults and children of DKA have been noted. Cerebral edema is a rare complication of DKA in adults and children, but the mortality and morbidity rates of this complication in children are high. Fetal mortality is a common complication of DKA, but maternal death is unusual. 32
33 Treatment for diabetic ketoacidosis should focus on fluid replacement, insulin therapy, correcting electrolyte abnormalities and acid-base disturbances, and monitoring for complications. If DKA if promptly recognized, properly and aggressively treated, and treatment outcomes appropriately evaluated and followed, patients should survive. For many people, diabetes requires lifestyle changes that they may not be willing to emotionally accept. Many cases of non-compliance happen because the patient has not been properly educated, or doesn t have or doesn t know how to get the resources needed. While all members of the health team have a role to support and educate patients with diabetes and history of DKA, nurses are often the first person to learn why a patient may not seek medical attention or lacks an understanding of diabetes and associated risks, such as unbalanced nutrition, infection and noncompliance to medication to treat diabetes and to prevent diabetic ketoacidosis. Please take time to help NurseCe4Less.com course planners evaluate the nursing knowledge needs met by completing the self-assessment of Knowledge Questions after reading the article, and providing feedback in the online course evaluation. Completing the study questions is optional and is NOT a course requirement. 33
34 1. Which of the following is the correct definition of diabetic ketoacidosis (DKA)? a. Metabolic disorder with hyperglycemia, metabolic acidosis, elevated ketones. b. Metabolic disorder with normal glucose, metabolic alkalosis, elevated ketones. c. Endocrine disorder caused by inappropriate insulin secretion. d. Endocrine disorder caused by abnormal carbohydrate metabolism. 2. The two most common causes of diabetic ketoacidosis (DKA) are: a. Atypical antipsychotics and gestational diabetes. b. Infection and poor compliance with medication regimens. c. CVA and pregnancy. d. Glucagon-producing tumors, sepsis. 3. The diagnostic criteria of diabetic ketoacidosis (DKA) include: a. A serum ph > 7.5, a serum glucose > 250 mg/dl. b. A serum ph < 7.30, a serum glucose < 250 mg/dl. c. A serum ph > 7.2, a serum glucose < 125 mg/dl. d. A serum ph < 7.3, a serum glucose > 250 mg/dl. 4. The serum potassium in diabetic ketoacidosis (DKA) is: a. Typically very low. b. Deceptively high: there is actually profound hypokalemia. c. Typically normal. d. Deceptively low: the total body content is normal. 5. Pregnant women who have diabetic ketoacidosis (DKA): a. Always have elevated serum glucose. b. Are rarely acidotic. c. May be euglycemic. d. Have a high mortality rate. 34
35 6. Young children are more likely to be vulnerable to which of the following diabetic ketoacidosis (DKA) complications? a. Cerebral edema. b. Hypokalemia. c. Renal failure. d. Cardiac arrhythmias. 7. The first step in treating diabetic ketoacidosis (DKA) is: a. Administration of insulin. b. Fluid resuscitation. c. Administration of bicarbonate. d. Potassium supplementation. 8. Patients with moderate to severe diabetic ketoacidosis (DKA) should be treated by using a. IV insulin or subcutaneous insulin. b. subcutaneous insulin. c. IV insulin. d. IM insulin. 9. The use of bicarbonate when treating diabetic ketoacidosis (DKA) a. Is reserved for children who have DKA. b. Is only indicated if the serum ph is < c. Is reserved for pregnant women who have DKA. d. Is only indicated if the serum ph is < When switching from continuous IV to subcutaneous insulin a. the IV infusion should be continued for several hours after starting subcutaneous insulin. b. The IV infusion should be stopped 1-2 hours before starting subcutaneous insulin. c. The IV infusion should be increased for 1-2 hours before starting subcutaneous insulin. d. The IV insulin should be continued for hours after starting subcutaneous insulin. 35
36 CORRECT ANSWERS: 1. Which of the following is the correct definition of diabetic ketoacidosis (DKA)? a. Metabolic disorder with hyperglycemia, metabolic acidosis, elevated ketones. Diabetic ketoacidosis is a very serious complication of diabetes mellitus, a metabolic disorder that is characterized by hyperglycemia, metabolic acidosis, and increased ketone body concentrations. 2. The two most common causes of diabetic ketoacidosis (DKA) are: b. Infection and poor compliance with medication regimens. The most common causes of diabetic ketoacidosis (DKA) are infection and poor compliance with medication regimens. 3. The diagnostic criteria of diabetic ketoacidosis (DKA) include: d. A serum ph < 7.3, a serum glucose > 250 mg/dl. MILD DKA - Glucose: > 250 mg/dl... Arterial ph: MODERATE DKA - Glucose: > 250 mg/dl... Arterial ph: SEVERE DKA - Glucose: > 250 mg/dl... Arterial ph: < The serum potassium in diabetic ketoacidosis (DKA) is: b. Deceptively high: there is actually profound hypokalemia. The serum potassium level may be high, but the patients are often very depleted of potassium... Hyponatremia is treated with infusion of IV saline solutions. A patient who has DKA often has a significant total body deficit of potassium, and the aggressive insulin therapy that is used to treat DKA can further lower serum potassium. Profound hypokalemia can have dire consequences and it should be treated aggressively. 36
37 5. Pregnant women who have diabetic ketoacidosis (DKA): c. May be euglycemic. If DKA in the pregnant woman is recognized early and treated properly, the outcome for the mother should be good;... if the condition is not recognized early in its development and/or the appropriate treatments are not given soon enough, serious maternal complications such as acute renal failure, adult respiratory distress syndrome, cerebral edema, euglycemic DKA, pre-term delivery, and myocardial ischemia are possible. 6. Young children are more likely to be vulnerable to which of the following diabetic ketoacidosis (DKA) complications? a. Cerebral edema. Finally, for several physiological reasons young children are more vulnerable to cerebral edema. Adolescents are more likely than adults to be non-compliant with their insulin regimen. 7. The first step in treating diabetic ketoacidosis (DKA) is: b. Fluid resuscitation. Treatment of DKA should begin with fluid replacement. 8. Patients with moderate to severe diabetic ketoacidosis (DKA) should be treated by using c. IV insulin. Patients who have moderate to severe DKA should be treated with IV insulin; patients who have mild DKA can be treated with subcutaneous insulin injections. 37
38 9. The use of bicarbonate when treating diabetic ketoacidosis (DKA) d. Is only indicated if the serum ph is < 6.9. Bicarbonate therapy should only be used if the serum ph is < 6.9, the patient has severe hyperkalemia, or if the acidosis is causing severe systemic effects. 10. When switching from continuous IV to subcutaneous insulin a. the IV infusion should be continued for several hours after starting subcutaneous insulin. Subcutaneous insulin can be started using the patient s previous insulin protocol. If the patient is insulin naïve, the clinician should administer units/kg a day along with bolus doses and basal insulin until the blood glucose is controlled. The IV insulin infusion should be continued for several hours after the first subcutaneous dose of insulin has been. 38
CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017
CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017 DKA at organ level 3 Diabetic Ketoacidosis Characteristics Ketones positive Anion Gap > 12 (High) Blood Sugar > 14 (High) Bicarbonate
More informationDiabetic Ketoacidosis
Diabetic Ketoacidosis Definition: Diabetic Ketoacidosis is one of the most serious acute complications of diabetes. It s more common in young patients with type 1 diabetes mellitus. It s usually characterized
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationHyperglycaemic Emergencies GRI EDUCATION
Hyperglycaemic Emergencies GRI EDUCATION LEARNING OUTCOMES Develop and describe your system of blood gas interpretation and recognise common patterns of acid-base abnormality. Describe the pathophysiology
More informationDIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor
DIABETES AND PREGNANCY CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor OBJECTIVES Describe targets for blood glucose in pregnancy Discuss the risks to baby if blood glucose
More informationDiabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State. Adam Bursua, Pharm.D., BCPS
Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State Adam Bursua, Pharm.D., BCPS Objectives Describe the epidemiology of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar
More information10. ACUTE COMPLICATIONS OF DIABETES MELLITUS
10. ACUTE COMPLICATIONS OF DIABETES MELLITUS Prof. Oren Zinder, Ph.D. Rambam Medical Center, and the Technion Faculty of Medicine, Haifa, Israel 1.1. Hypoglycaemia Hypoglycaemia is a lowered blood glucose
More informationDIABETES MELLITUS. IAP UG Teaching slides
DIABETES MELLITUS 1 DIABETES MELLITUS IN CHILDREN Introduction, Definition Classification, pathogenesis Clinical features Investigations and diagnosis Therapy and follow up Complications Carry home message
More informationDKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014
DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol Glycemic Task Force September 2014 Hyperglycemic Crises: Pathophysiology DKA HHS Hyperglycemia DKA HHS Umpierrez, In Shoemaker,
More informationObstetrics Guidelines. B. Maternal mortality rates are generally less than 1%.
Page: 1 of 8 SUBJECT: DIABETIC KETOACIDOSIS IN PREGNANCY I. Overview A. Diabetic ketoacidosis (DKA) is an acute medical emergency associated with fetal loss rates in excess of 50%. B. Maternal mortality
More informationChapter Goal. Learning Objectives 9/12/2012. Chapter 25. Diabetic Emergencies
Chapter 25 Diabetic Emergencies Chapter Goal Use assessment findings to formulate field impression & implement treatment plan for patients with diabetic emergencies Learning Objectives Describe pathophysiology
More information9/11/2012. Chapter 11. Learning Objectives. Learning Objectives. Endocrine Emergencies. Differentiate type 1 and type 2 diabetes
Chapter 11 Endocrine Emergencies Learning Objectives Differentiate type 1 and type 2 diabetes Explain roles of glucagon, glycogen, and glucose in hypoglycemia Learning Objectives Discuss following medications
More informationIV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations
IV Fluids When administering IV fluids, the type and amount of fluid may influence patient outcomes. Make sure to understand the differences between fluid products and their effects. Crystalloids Crystalloid
More informationDiabetic Ketoacidosis
October 2015 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Case History HPI: 24 yo man with recent 8 lb. weight loss, increased thirst and frequent
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationObjectives / Learning Targets: The learner who successfully completes this course will be able to demonstrate understanding of the following concepts:
Objectives / Learning Targets: The learner who successfully completes this course will be able to demonstrate understanding of the following concepts: Insulin s function in the body. The basics of diabetes
More informationDIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1
DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1 QUESTION # 1 7 year old boy comes to the ER with a 2 week history of abdominal pain and weight loss. Further history reveals polyuria and polydipsia,
More informationWith Dr. Sarah Reid and Dr. Sarah Curtis
5. Headaches 6. Known diabetes 7. Specific high risk groups (ie. Teenagers, children on insulin pumps and those from lower socio-economic status). Episode 63 Pediatric Diabetic Ketoacidosis With Dr. Sarah
More informationI have no financial disclosures
Athina Sikavitsas DO Children's Emergency Services University of Michigan Discuss DKA Presentation Assessment Treatment I have no financial disclosures 1 6 Y/O male presents with vomiting and abdominal
More informationAcid-Base Balance 11/18/2011. Regulation of Potassium Balance. Regulation of Potassium Balance. Regulatory Site: Cortical Collecting Ducts.
Influence of Other Hormones on Sodium Balance Acid-Base Balance Estrogens: Enhance NaCl reabsorption by renal tubules May cause water retention during menstrual cycles Are responsible for edema during
More informationDiabetic Emergencies in Pregnancy. Brian A. Mason, MS, MD
Diabetic Emergencies in Pregnancy Brian A. Mason, MS, MD Objectives Recognize the three major risks of major morbidity in the diabetic gravida. Treat these 3 risks promptly and effectively. Diabetic Emergencies
More informationFor The Management Of. Diabetic Ketoacidosis
Guidelines For The Management Of Diabetic Ketoacidosis By Dr. Sinan Butrus F.I.C.M.S Clinical Standards & Guidelines Dr.Layla Al-Shahrabani F.R.C.P (UK) Director of Clinical Affairs Kurdistan Higher Council
More informationCCRN/PCCN Review Course May 30, 2013
A & P Review CCRN/PCCN Review Course May 30, 2013 Endocrine Anterior pituitary Growth hormone: long bone growth Thyroid stimulating hormone: growth, thyroid secretion Adrenocorticotropic hormone: growth,
More informationDiabetes mellitus - diagnosis, classification and acute complications. David Karásek 3rd Department of Internal Medicine University Hospital Olomouc
Diabetes mellitus - diagnosis, classification and acute complications David Karásek 3rd Department of Internal Medicine University Hospital Olomouc Diabetes mellitus is a group of metabolic diseases, characterized
More informationBasic Fluid and Electrolytes
Basic Fluid and Electrolytes Chapter 22 Basic Fluid and Electrolytes Introduction Infants and young children have a greater need for water and are more vulnerable to alterations in fluid and electrolyte
More informationAACN PCCN Review. Endocrine
AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders
More informationCalcium (Ca 2+ ) mg/dl
Quick Guide to Laboratory Values Use this handy cheat-sheet to help you monitor laboratory values related to fluid and electrolyte status. Remember, normal values may vary according to techniques used
More informationWATER, SODIUM AND POTASSIUM
WATER, SODIUM AND POTASSIUM Attila Miseta Tamás Kőszegi Department of Laboratory Medicine, 2016 1 Average daily water intake and output of a normal adult 2 Approximate contributions to plasma osmolality
More informationMetformin Hydrochloride
Metformin Hydrochloride 500 mg, 850 mg, 500 mg LA and 750 mg LA Tablet Description Informet is a preparation of metformin hydrochloride that belongs to a biguanide class of oral antidiabetic drugs. Metformin
More informationThe Mentally Altered Diabetic Diagnosis and Management of Hyperosmolar Hyperglycemic Syndrome Christy Michael, BVMS, MBA
The Mentally Altered Diabetic Diagnosis and Management of Hyperosmolar Hyperglycemic Syndrome Christy Michael, BVMS, MBA Introduction When a mentally altered patient arrives on the scene at any veterinary
More informationSalicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes
Salicylate (Aspirin) Ingestion California Poison Control 1-800-876-4766 Background 1. The prevalence of aspirin-containing analgesic products makes these agents, found in virtually every household, common
More informationChapter 26 Fluid, Electrolyte, and Acid- Base Balance
Chapter 26 Fluid, Electrolyte, and Acid- Base Balance 1 Body Water Content Infants: 73% or more water (low body fat, low bone mass) Adult males: ~60% water Adult females: ~50% water (higher fat content,
More informationDiabetic Emergencies. Chapter 15
Diabetic Emergencies Chapter 15 Diabetes- is a disorder of glucose metabolism or difficulty metabolizing carbohydrates, fats and proteins Full name is diabetes mellitus which refers to the presence of
More informationPediatric Diabetic Ketoacidosis Guidelines
Pediatric Diabetic Ketoacidosis Guidelines For new onset diabetes in a pediatric patient NOT in DKA (see criteria below) These guidelines may not be appropriate Consult endocrine and pediatric admit resident
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Diabetic Ketoacidosis. These podcasts are designed to give medical students an overview of key topics in pediatrics.
More informationName: Oasis: Questions EPCP. Professional Development: Diabetes
EPCP Professional Development: Diabetes Name: Oasis: Questions 1) Type 1 diabetes in characterized by which of the following: 1) adult onset, obesity 2) juvenile onset, lean build 3) auto-immune beta cell
More informationDiabetic ketoacidosis and. adults. By Dr Karimifar Assistant Prof. of Endocrinology Isfahan University of Medical Sciences
IN THE NAME OF GOD Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults By Dr Karimifar Assistant Prof. of Endocrinology Isfahan University of Medical Sciences DKA AND HHS Diabetic ketoacidosis
More informationCCRN Review - Renal. CCRN Review - Renal 10/16/2014. CCRN Review Renal. Sodium Critical Value < 120 meq/l > 160 meq/l
CCRN Review Renal Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Sodium 136-145 Critical Value < 120 meq/l > 160 meq/l Sodium Etiology
More informationAcid Base Balance. Professor Dr. Raid M. H. Al-Salih. Clinical Chemistry Professor Dr. Raid M. H. Al-Salih
Acid Base Balance 1 HYDROGEN ION CONCENTRATION and CONCEPT OF ph Blood hydrogen ion concentration (abbreviated [H + ]) is maintained within tight limits in health, with the normal concentration being between
More informationMultiple c hoice q uestions
Multiple c hoice q uestions Chapter 1 1. The pathogenesis of hyperglycemia in diabetic ketoacidosis includes all the following mechanisms except for: a. Increased glycogenolysis in the liver b. Increased
More informationdiabetes in adults Metabolic complications of
Metabolic complications of diabetes in adults Dimitri MARGETIS MD ICU St ANTOINE PARIS Definition Diabetic acidoketosis Serious complication in type I diabetes : Hyperglycemia Metabolic acidosis Acidic
More informationNothing to disclose. Disclosure
Nothing to disclose. Disclosure Inpatient Management of Diabetes Mellitus Cindy Chin, MD Pediatrics in the Red Rocks 2015 Objectives Name 3 diagnostic criteria for diabetes mellitus. Understand and apply
More informationType I diabetes mellitus. Dr Laurence Lacroix
mellitus Dr Laurence Lacroix 26.03.2014 1 DEFINITION: Group of diseases characterized by a disorder of glucose homeostasis with high levels of blood glucose resulting from defects in : o insulin production
More informationAnne Leake, PhD, APRN, BC-ADM ECHO Diabetes Learning Group 4/4/18. High Sugar / Hyperglycemia: Causes, Complications and Management
Anne Leake, PhD, APRN, BC-ADM ECHO Diabetes Learning Group 4/4/18 High Sugar / Hyperglycemia: Causes, Complications and Management Case Presentation A 45 year old obese man comes to your clinic with a
More informationLynda Astbury Lead Diabetes Specialist Nurse
Lynda Astbury Lead Diabetes Specialist Nurse WARNING SIGNS AND SYMPTOMS Is patient Feeling unwell? Blood glucose level above 13mmol/L Or higher than the patients day to day readings (even if not eating)
More informationHypoglycemia, Electrolyte disturbances and acid-base imbalances
Hypoglycemia, Electrolyte disturbances and acid-base imbalances Pediatric emergency PICU division Pediatric department Medical faculty, University of Sumatera Utara H. Adam Malik Hospital 1 Hypoglycemia
More informationDiabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016
Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features
More information1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown
Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 7 Caring for Clients with Altered Fluid, Electrolyte, or Acid-Base Balance Water Primary component of
More informationCASE 27. What is the response of the kidney to metabolic acidosis? What is the response of the kidney to a respiratory alkalosis?
CASE 27 A 21-year-old man with insulin-dependent diabetes presents to the emergency center with mental status changes, nausea, vomiting, abdominal pain, and rapid respirations. On examination, the patient
More informationDr. Dafalla Ahmed Babiker Jazan University
Dr. Dafalla Ahmed Babiker Jazan University objectives Overview Definition of dehydration Causes of dehydration Types of dehydration Diagnosis, signs and symptoms Management of dehydration Complications
More informationVinaya Simha, M.D. Assistant Professor, Division of Endocrinology
Vinaya Simha, M.D. Assistant Professor, Division of Endocrinology Faculty photo will be placed here Simha.aj@mayo.edu 2015 MFMER 3543652-1 Diabetic Ketoacidosis a few pearls Mayo School of Continuous Professional
More informationAssessment of the Patient with Endocrine Dysfunction. Objective. Endocrine. Endocrine Facts. Physical Assessment 10/3/2013
Objective Endocrine Jennifer MacDermott, MS, RN, ACNS BC, NP C, CCRN Clinical Nurse Specialist Surgical Intensive Care Unit Identify abnormal assessment finding sin a patient with endocrine dysfunction.
More informationChapter 16 Nutrition, Fluids and Electrolytes, and Acid-Base Balance Nutrition Nutrients Water o Functions Promotes metabolic processes Transporter
Chapter 16 Nutrition, Fluids and Electrolytes, and Acid-Base Balance Nutrition Nutrients Water o Functions Promotes metabolic processes Transporter for nutrients and wastes Lubricant Insulator and shock
More informationChapter 20 8/23/2016. Fluids and Electrolytes. Fluid (Water) Fluid (Water) (Cont.) Functions
Chapter 20 Fluids and Electrolytes All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Fluid (Water) Functions Provides an extracellular transportation
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More informationUNIT VI: ACID BASE IMBALANCE
UNIT VI: ACID BASE IMBALANCE 1 Objectives: Review the physiological mechanism responsible to regulate acid base balance in the body i.e.: Buffers (phosphate, hemoglobin, carbonate) Renal mechanism Respiratory
More informationDKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate
Approved by Diabetes Steering Committee, MMC, 2015 DKA/HHS Pathway Phase 1 (Adult) DKA Diagnostic Criteria (See page 3 for more details): Blood glucose >250 mg/dl, Arterial ph
More informationKENT STATE UNIVERSITY HEALTH CARE OF CHILDREN Nursing Pediatrics Case Studies: Child Dehydration
Courtney Wiener 9/9/10 KENT STATE UNIVERSITY HEALTH CARE OF CHILDREN Nursing 30020 - Pediatrics Case Studies: Child Dehydration Introduction: Dehydration can be life threatening to a child since a majority
More informationMajor intra and extracellular ions Lec: 1
Major intra and extracellular ions Lec: 1 The body fluids are solutions of inorganic and organic solutes. The concentration balance of the various components is maintained in order for the cell and tissue
More informationAcid Base Balance. Chapter 26 Balance. ph Imbalances. Acid Base Balance. CO 2 and ph. Carbonic Acid. Part 2. Acid/Base Balance
Acid Base Balance Chapter 26 Balance Part 2. Acid/Base Balance Precisely balances production and loss of hydrogen ions (ph) The body generates acids during normal metabolism, tends to reduce ph Kidneys:
More informationTable 1. Common precipitating events of DKA.
Update in Anaesthesia Diabetic ketoacidosis Claire Preedy and William English Correspondence Email: englishwilliam@hotmail.com DEFINITION Diabetes ketoacidosis (DKA) is a medical emergency. It is classified
More informationAmjad Bani Hani Ass.Prof. of Cardiac Surgery & Intensive Care FLUIDS AND ELECTROLYTES
Amjad Bani Hani Ass.Prof. of Cardiac Surgery & Intensive Care FLUIDS AND ELECTROLYTES Body Water Content Water Balance: Normal 2500 2000 1500 1000 500 Metab Food Fluids Stool Breath Sweat Urine
More informationELECTROLYTES RENAL SHO TEACHING
ELECTROLYTES RENAL SHO TEACHING Metabolic Alkalosis 2 factors are responsible for generation and maintenance of metabolic alkalosis this includes a process that raises serum bicarbonate and a process that
More informationAcids, Bases, and Salts
Acid / Base Balance Objectives Define an acid, a base, and the measure of ph. Discuss acid/base balance, the effects of acidosis or alkalosis on the body, and the mechanisms in place to maintain balance
More informationHypoglycemia in congenital hyperinsulinism
How a normal body works: Our body is constantly at work. Our cells need a source of energy, and this source of energy is called glucose. The process is quite simple; think of it like an assembly line.
More informationNursing Process Focus: Patients Receiving Dextran 40 (Gentran 40)
Assess for presence/history of hypovolemia, shock, venous thrombosis. Assess vital signs: Hypovolemic shock secondary to surgery, burns, hemorrhage, other serious condition PT and PTT abnormalities Venous
More informationTOO SWEET TOO STORMY. CONSULTANTS: Dr. Saji James Dr. J. Dhivyalakshmi Dr. P. N. Vinoth. PRESENTOR: Dr. Abhinaya PG I (M.D Paeds)
TOO SWEET TOO STORMY PRESENTOR: Dr. Abhinaya PG I (M.D Paeds) CONSULTANTS: Dr. Saji James Dr. J. Dhivyalakshmi Dr. P. N. Vinoth Unit IV, Dept. Of Paediatrics, SRMC & RI 14year old female complaints of
More informationDedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden
Managing Diabetes in the Athletic Population Dedicated To Aiden Michael Prybicien, LA, ATC, CSCS, CES, PES Athletic Trainer, Passaic High School Overlook Medical Center & Adjunct Faculty, William Paterson
More informationDiuretic Use in Neonates
Neonatal Nursing Education Brief: Diuretic Use in the Neonate http://www.seattlechildrens.org/healthcareprofessionals/education/continuing-medical-nursing-education/neonatalnursing-education-briefs/ Diuretics
More informationArterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)
Page 1 of 6 Hyperglycemic Emergency Management (DKA/HHS 1 ) - Adult PATIENT PRESENTATION Patient with history of Type 1 or 2 Diabetes Mellitus or presenting with polyuria, polydipsia, nausea/ vomiting,
More informationSupplement Table 1. Definitions for Causes of Death
Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death
More informationElectrolytes Solution
Electrolytes Solution Substances that are not dissociated in solution are called nonelectrolytes, and those with varying degrees of dissociation are called electrolytes. Urea and dextrose are examples
More informationWk 10. Management of Clients with Diabetes Mellitus
Wk 10. Management of Clients with Diabetes Mellitus 2. Acute complications of DM 1) Hyperglycemia and diabetic ketoacidosis Hyperglycemia: glycogenolysis gluconeogenesis 1) Etiology and Risk Factors Taking
More informationArterial blood gas Capillary blood glucose every hour. Continue to monitor hourly capillary blood glucose as per protocol (See Appendix A and B)
Page 1 of 6 Hyperglycemic Emergency Management (DKA/HHS 1 ) - Adult PATIENT PRESENTATION Patient with history of Type 1 or 2 Diabetes Mellitus or presenting with polyuria, polydipsia, nausea/ vomiting,
More informationGeorge Ford MD MS Assistant Professor Pediatric Endocrinology ETSU and Niswonger Children s Hospital
George Ford MD MS Assistant Professor Pediatric Endocrinology ETSU and Niswonger Children s Hospital Disclosure Statement of Financial Interest I, George Ford MD MS, DO NOT have a financial interest/arrangement
More informationCEDIAMATE Metformin Tablets USP 500 mg
CEDIAMATE Metformin Tablets USP 500 mg COMPOSITION: Cediamate Each un-coated tablet contains: Metformin Hydrochloride USP Excipients 500 mg Q.S PHARMACOLOGY: Pharmacotherapeutic group: Blood Glucose lowering
More informationComposition: Each Tablet contains. Pharmacokinetic properties:
Composition: Each Tablet contains Torsemide 5/10/20/40/100mg Pharmacokinetic properties: Torsemide is well absorbed from the gastrointestinal tract. Peak serum concentrations are achieved within 1 hour
More informationDiabetes Review. October 31, Dr. Don Eby Tracy Gaunt Dwayne Cottel
Diabetes Review October 31, 2012 Dr. Don Eby Tracy Gaunt Dwayne Cottel Diabetes Review Learning Objectives: Describe the anatomy and physiology of the pancreas Describe the effects of hormones on the maintenance
More informationCHAPTER 27 LECTURE OUTLINE
CHAPTER 27 LECTURE OUTLINE I. INTRODUCTION A. Body fluid refers to body water and its dissolved substances. B. Regulatory mechanisms insure homeostasis of body fluids since their malfunction may seriously
More informationCombining Complex Pathophysiologic Concepts: Diabetes Mellitus
Chapter 18 Combining Complex Pathophysiologic Concepts: Diabetes Mellitus KEY TERMS dawn phenomenon diabetes mellitus endocrine pancreas exocrine pancreas hyperglycemia hyperketonemia hypoglycemia insulin
More informationAcid Base Balance by: Susan Mberenga RN, BSN, MSN
Acid Base Balance by: Susan Mberenga RN, BSN, MSN Acid Base Balance Refers to hydrogen ions as measured by ph Normal range: 7.35-7.45 Acidosis/acidemia: ph is less than 7.35 Alkalosis/alkalemia: ph is
More informationNeonatal Fluid Therapy Not my mother s physiology!!
Neonatal Fluid Therapy Not my mother s physiology!! Physiologic Approach to Neonatal Fluid Therapy General principles of fluid balance Fetal physiology of fluid balance Neonatal physiology of fluid balance
More informationARTERIAL BLOOD GASES PART 1 BACK TO BASICS SSR OLIVIA ELSWORTH SEPT 2017
ARTERIAL BLOOD GASES PART 1 BACK TO BASICS SSR OLIVIA ELSWORTH SEPT 2017 WHAT INFORMATION DOES AN ABG GIVE US? ph = measure of hydrogen ion concentration (acidity or alkalinity) PaCO2 = partial pressure
More informationPrinciples of Anatomy and Physiology
Principles of Anatomy and Physiology 14 th Edition CHAPTER 27 Fluid, Electrolyte, and Acid Base Fluid Compartments and Fluid In adults, body fluids make up between 55% and 65% of total body mass. Body
More informationDIABETIC KETOACIDOSIS MANAGEMENT PLAN:
DIABETIC KETOACIDOSIS MANAGEMENT PLAN: 1. Assessment (weight, blood glucose level (BGL), blood pressure (BP), heart rate (HR), respiratory rate (RR), temperature, history & examination) 2. Resuscitation
More informationEmergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: Endocrine Revised: 11/2013
Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: Endocrine Revised: 11/2013 Endocrine system includes 8 major glands. 1. Pituitary (master gland)
More informationPediatric Diabetic Ketoacidosis (DKA) General Pediatrics Admission Order Set
Admitting MRP: Pediatrics: Dr. / Dr. on call to cover until 08:00 am Service: Medicine Team 1 Medicine Team 2 Medical subspecialty Diagnosis: Diabetic Ketoacidosis (DKA) Estimated length of stay Less than
More informationMetabolic Alkalosis: Vomiting
RENAL ANL) ACID-BASE PHYSIOLOGY 213 Case 37 Metabolic Alkalosis: Vomiting Maria Cuervo is a 20-year-old philosophy major at a state university. When the "24-hour" stomach flu went around campus during
More informationPediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University
Pediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University SHOCK Definition: Shock is a syndrome = inability to provide sufficient oxygenated blood to tissues. Oxygen
More informationChapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories
Chapter 23 Drugs for Hypertension Slide 37 Slide 41 Media Directory Nifedipine Animation Doxazosin Animation Upper Saddle River, New Jersey 07458 All rights reserved. Cardiovascular Disease (CVD) Includes
More informationDiabetic Ketoacidosis (DKA) v4.0: Links and Clinical Tools
Diabetic Ketoacidosis (DKA) v4.0: Exclusion and Inclusion Criteria Pathway Overview DKA Risk Assessment ICU Admission Criteria Cerebral Edema Where Should the Child be Managed? PHASE 1: Early Electrolyte
More informationDiabetes Mellitus Case Study
COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the
More informationDiabetic ketoacidosis (DKA) Hyperglycemic Crisis in Adults: Pathophysiology, Presentation, Pitfalls, and Prevention. Michael Fowler, MD
Hyperglycemic Crisis in Adults: Pathophysiology, Presentation, Pitfalls, and Prevention Michael Fowler, MD Editor s note: This article is the 9th in a 12-part series reviewing the fundamentals of diabetes
More informationDiabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System
Critical Care Guideline Two Bag System Inclusion Criteria (Definition of DKA): Blood glucose (BG) > 200 mg/dl Acidosis (bicarbonate < 15 or blood gas ph < 7.3) Associated glycosuria, ketonuria &/or ketonemia
More informationCase TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air
Mr N is a 64year old Chinese gentleman who is a heavy drinker, still actively drinking, and chronic smoker of >40pack year history. He has a past medical history significant for Hypertension, Hyperlipidemia,
More informationAcid-Base Imbalance-2 Lecture 9 (12/4/2015) Yanal A. Shafagoj MD. PhD
AcidBase Imbalance2 Lecture 9 (12/4/2015) Yanal A. Shafagoj MD. PhD Introduction Disturbance in acidbase balance are common clinical problem that range in severity from mild to life threatening, the acute
More informationAcid-base balance is one of the most important of the body s homeostatic mechanisms Acid-base balance refers to regulation of hydrogen ion (H + )
Acid-base balance is one of the most important of the body s homeostatic mechanisms Acid-base balance refers to regulation of hydrogen ion (H + ) concentration in body fluids Precise regulation of ph at
More informationAcid-Base Balance Workshop. Dr. Najla Al Kuwaiti Dr. Abdullah Al Ameri Dr. Amar Al Shibli
Acid-Base Balance Workshop Dr. Najla Al Kuwaiti Dr. Abdullah Al Ameri Dr. Amar Al Shibli Objectives Normal Acid-Base Physiology Simple Acid-Base Disorders Compensations and Disorders The Anion Gap Mixed
More informationBUFFERING OF HYDROGEN LOAD
BUFFERING OF HYDROGEN LOAD 1. Extracellular space minutes 2. Intracellular space minutes to hours 3. Respiratory compensation 6 to 12 hours 4. Renal compensation hours, up to 2-3 days RENAL HYDROGEN SECRETION
More informationFluid, electrolyte, and acid-base balance
Fluid, electrolyte, and acid-base balance Chapter 50 Ra'eda Almashaqba 1 Fluid, electrolyte, and acid-base balance About 46% to 60%of the average adult's weight is water, which is vital to health and normal
More information